Optimizing the use of angiogenesis inhibitor in neovascular age-related macular degeneration

Optimizing the use of angiogenesis inhibitor in neovascular age-related macular degeneration

The purpose of the study was to estimate the effectiveness of using ranibizumab in combination with medotilin drug in the treatment of neovascular age-related macular degeneration (AMD). Material and methods. 50 patients (65 eyes) aged 41 to 88 (ave. 68.5 ± 0.98 years) with neovascular AMD were foll...

Full description

Saved in:

Bibliographic Details
Main Authors:	F. A. Bakhritdinova, A. F. Yusupov, Sh. A. Mukhanov
Format:	Article
Language:	Russian
Published:	Real Time Ltd 2018-10-01
Series:	Российский офтальмологический журнал
Subjects:	возрастная макулярная дегенерация хроническая неоваскуляризация ранибизумаб медотилин электроретинография age-related macular degeneration chronic neovascularization ranibizumab medotilin electroretinography
Online Access:	https://roj.igb.ru/jour/article/view/69
Tags:	Add Tag No Tags, Be the first to tag this record!

Similar Items

Pathogenetic issues of retinal dystrophies associated with myopia and agerelated macular degeneration
by: I. B. Alekseev, et al.
Published: (2018-10-01)

Functional express testing and self monitoring in the diagnosis and treatment of macular diseases
by: S. O. Milyutkina, et al.
Published: (2018-10-01)

The Effectiveness of Retinalamin® Administered by Various Intramuscular Injection Timings in the Treatment of Patients with the Dry Form of Age- Related Macular Degeneration
by: V. V. Neroev, et al.
Published: (2018-10-01)

Efficacy of aflibercept in patients with neovascular age-related macular degeneration when combined with cataract surgery
by: A. A. Kuznetsov, et al.
Published: (2018-10-01)

The results of a long-term follow up of patients with age-related macular degeneration who received a lutein-containing medication
by: O. V. Zaytseva, et al.
Published: (2018-10-01)

THE PROGNOSTIC VALUE OF PHARMACOLOGICAL AND GENETIC TESTING IN MEDICAL THERAPY OF AGE-RELATED MACULAR DEGENERATION
by: N. A. Bakunina, et al.
Published: (2018-10-01)

РАЗРАБОТКА РЕЦЕПТУРЫ САХАРНОГО ПЕЧЕНЬЯ ДЛЯ ПОТРЕБИТЕЛЕЙ С ПРЕДРАСПОЛОЖЕННОСТЬЮ К ВОЗРАСТНОЙ МАКУЛЯРНОЙ ДЕГЕНЕРАЦИИ
by: Мария Владимировна Чубарова, et al.
Published: (2022-03-01)

Assessment of effect of intravitreal ranibizumab injection on the ocular blood flow in patients with neovascular age-related macular degeneration
by: V. V. Neroev, et al.
Published: (2014-07-01)

Effect of vascular endothelial growth factor inhibitors on choroid in patients with macular choroid neovascular membrane and degenerative myopia . Preliminary report
by: V. A. Solomin, et al.
Published: (2014-07-01)

Clinical effectiveness of nutrof total supplement for Dry age-related macular Degeneration
by: E. N. Eskina, et al.
Published: (2018-10-01)

Anti-VEGF therapy of neovascular age-related macular degeneration: from randomized trials to routine clinical practice
by: R. R. Fayzrakhmanov
Published: (2019-06-01)

Incidence and Clinical Practice of Myopic Macular Neovascularization: A Nationwide Population-Based Cohort Study
by: Masahiro Akada, MD, et al.
Published: (2025-11-01)

СНИЖЕНИЕ ИНСТРУМЕНТАЛЬНОЙ ФУНКЦИОНАЛЬНОЙ АКТИВНОСТИ ПАЦИЕНТОВ С САРКОПЕНИЧЕСКИМ ОЖИРЕНИЕМ И ВОЗРАСТ-АССОЦИИРОВАННОЙ ПАТОЛОГИЕЙ ОРГАНА ЗРЕНИЯ
by: Николай Михайлович Агарков, et al.
Published: (2025-06-01)

Efficacy and safety of intravitreal anti-VEGF for myopic choroidal neovascularization
by: Jing-Yao Liu, et al.
Published: (2025-09-01)

CLINICAL EFFECTIVENESS OF NEUROTRANSMITTERS PATIENTS WITH PRIMARY GLAUCOMA VEGF INHIBITOR IN PATIENTS WITH CHOROIDAL NEOVASCULARIZATION CAUSED BY DEGENERATIVE MYOPIA
by: L. P. Danilova, et al.
Published: (2016-09-01)

Comparative efficacy and safety of Faricimab with other intravitreal anti-vascular endothelial growth factor in the treatment of Neovascular age related macular degeneration- A Systematic review and meta-analysis
by: Renuga Devi Kaliaperumal, et al.
Published: (2025-05-01)

Irvine - Gass Syndrome Treatment in Extracapsular Pseudophakia Using Intravitreal Injections. A Clinical Case
by: I. E. Ioshin, et al.
Published: (2018-10-01)

Bioelectric Activity of the Macula and Light Sensitivity in Retinitis Pigmentosa with Foveal Atrophy and Cystoid Macular Oedema
by: I. V. Zolnikova, et al.
Published: (2018-10-01)

Clinical Evaluation of the Effectiveness of Neovascular Age-related Macular Degeneration Combined Treatment
by: L. A. Golota, et al.
Published: (2025-03-01)

Intravitreal Ranibizumab for Treatment of Posttraumatic Choroidal Neovascularization: a Case Report
by: A. N. Kulikov, et al.
Published: (2021-10-01)

Photodynamic therapy for neovascular age-related macular degeneration
by: Richard P.L. Wormald, MA, MB, BCh, MSc, FRCS, FRCOphth, et al.
Published: (2005-06-01)

HISTOLOGY AND HISTOPATHOLOGY OF BLOOD VESSELS: BACKSCATTERED SCANNING ELECTRON MICROSCOPY APPROACH
by: RINAT A. Mukhamadiyarov, et al.
Published: (2019-03-01)

A New Anti-VEGF Inhibitor, Aflibercept: Treatment Outcomes Of Neovascular Macular Degeneration Refractory To Other Anti-VEGF Agents
by: Kiran Turaka
Published: (2014-04-01)

Early detection of choroidal neovascularization in age related macular degeneration
by: Tural Galbinur
Published: (2014-07-01)

Metformin inhibits pathological retinal neovascularization but promotes retinal fibrosis in experimental neovascular age-related macular degeneration
by: Xin Wang, et al.
Published: (2025-03-01)

Comparison of visual acuity outcome and choroidal thickness variation of intravitreal ranibizumab injection for myopic choroidal neovascularization with or without dome-shaped macula
by: Xiao-Fang Yin, et al.
Published: (2024-12-01)

Research progress in molecular omics of neovascular age-related macular degeneration
by: ZHUANG Xuenan, et al.
Published: (2025-02-01)

Evaluation of the efficacy of surgical treatment of cataracts in patients with neovascular age-related macular degeneration
by: A. Zh. Fursova, et al.
Published: (2024-12-01)

Adherence to Anti-VEGF Treatment in Patients with Neovascular Age-Related Macular Degeneration: A Real-World Study
by: Mekala Shellvarajah, et al.
Published: (2025-04-01)

Intravitreal bevacizumab for neovascular age-related macular degeneration
by: Junn R. Pajarillo, MD, et al.
Published: (2009-12-01)

Рhotopic Negative Response for Testing the Function of Inner Retina: Registration Requirements and Comparison in the Eyes with Natural Pupil Width and in Conditions of Drug Mydriasis
by: V. I. Kotelin, et al.
Published: (2020-09-01)

Principles of anti-VEGF dosing in the treatment of neovascular age-related macular degeneration
by: I. E. Ioshin, et al.
Published: (2019-08-01)

The Vascular Architecture of Macular Neovascularization in Age-Related Macular Degeneration as a Predictor of Therapy Requirements: A 3-Year Longitudinal Analysis
by: Michael Grün, et al.
Published: (2025-04-01)

Clinical Response To Switch From Ranibizumab To Aflibercept In Wet Age-Related Macular Degeneration
by: Bhagya Weerasinghe, et al.
Published: (2021-01-01)

Comparison of OCT Angiography Parameters after Administration of Intravitreal Brolucizumab versus Ranibizumab in Exudative Age-related Macular Degeneration
by: Sanjitha Vilma Moses, et al.
Published: (2024-12-01)

Choroidal neovascularization activity and structure by optical coherence tomography angiography in age related macular degeneration
by: M. A. Kovalevskaya, et al.
Published: (2021-12-01)

Two-year results of switching to intravitreal administration of faricimab in patients with aflibercept-refractory neovascular age-related macular degeneration
by: Masaaki Saito, et al.
Published: (2025-08-01)

Analysis of Clinical Study Results Obtained in Patients with Neovascular Age-Related Macular Degeneration in 2005–2020. Review
by: N. A. Gavrilova, et al.
Published: (2022-04-01)

Clinical, functional and aberrometric parallels in the treatment of the neovascular form of age-related macular degeneration
by: M. M. Magomedova, et al.
Published: (2024-07-01)

The results of diagnostic and treatment of patients with diabetic retinopathy and age-related macular degeneration at a diabetes type 2.
by: I. V. Vorobyova, et al.
Published: (2014-10-01)